ProCE Banner Activity

Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes

Multimedia
Listen as faculty review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD. Review treatment strategies for managing patients with uILD and hear expert perspectives on the clinical trial findings of emerging treatments.

Released: August 05, 2021

Expiration: August 04, 2022

No longer available for credit.

Share

Faculty

Toby Maher

Toby Maher, MD, PhD, FRCP

Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Southern California
Director of Interstitial Lung Disease
Division of Pulmonary, Critical Care, and Sleep Medicine
Keck Medicine of USC
Los Angeles, California

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Toby Maher, MD, PhD, FRCP

Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Southern California
Director of Interstitial Lung Disease
Division of Pulmonary, Critical Care, and Sleep Medicine
Keck Medicine of USC
Los Angeles, California